Meng Xie Selected Research

Meng Xie Research Topics

Disease

31	Neoplasms (Cancer) 01/2024 - 01/2012
16	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2018
10	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 10/2014
4	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 11/2023
4	Infections 02/2024 - 08/2020
4	Inflammation (Inflammations) 11/2023 - 01/2014
2	Liver Neoplasms (Liver Cancer) 01/2024 - 10/2014
2	Laryngopharyngeal Reflux 11/2022 - 11/2021
2	Erythema 11/2022 - 11/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2022 - 01/2013
2	Carcinoma (Carcinomatosis) 06/2022 - 10/2014
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2012
2	Hypertrophy 11/2021 - 06/2018
2	Hemorrhage 06/2021 - 08/2020
2	Carcinogenesis 01/2021 - 01/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 12/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 01/2018
1	Cognitive Dysfunction 03/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2024
1	Obesity 01/2024
1	Viremia 11/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	COVID-19 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Adenocarcinoma of Lung 01/2023
1	Healthcare-Associated Pneumonia 12/2022
1	Chronic Cough 11/2022
1	Hyperemia 11/2022
1	Blastocystis Infections 10/2022
1	Apnea 10/2022
1	Nervous System Diseases (Neurological Disorders) 10/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2022

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2016
6	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020 - 01/2012
4	molybdenum disulfideIBA 11/2023 - 03/2020
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
4	LipidsIBA 05/2022 - 01/2012
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2019
3	ChitosanIBA 01/2021 - 08/2013
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
2	NitrogenIBA 03/2024 - 11/2023
2	Amyloid (Amyloid Fibrils)IBA 03/2024 - 11/2023
2	MetalsIBA 03/2024 - 11/2023
2	Messenger RNA (mRNA)IBA 02/2024 - 11/2023
2	CarbonIBA 11/2023 - 03/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 01/2015
2	fisogatinibIBA 01/2023 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2022
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2022 - 10/2013
2	Pepsin A (Pepsin)IBA 11/2022 - 11/2021
2	Oxygen (Dioxygen)IBA 10/2022 - 03/2020
2	defactinibIBA 09/2022 - 01/2022
2	Monomeric GTP-Binding ProteinsIBA 01/2022 - 01/2022
2	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2022 - 01/2021
2	Insulin-Like PeptidesIBA 01/2022 - 01/2021
2	NSC 23766IBA 01/2022 - 01/2020
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2021 - 11/2021
2	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 11/2021 - 01/2021
2	graphene oxideIBA 06/2021 - 04/2019
2	MicroRNAs (MicroRNA)IBA 08/2019 - 01/2018
2	AlginatesIBA 04/2019 - 08/2013
2	Methotrexate (Mexate)FDA LinkGeneric 02/2018 - 12/2017
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2014 - 10/2013
1	polydopamineIBA 03/2024
1	Caspase 8 (Caspase-8)IBA 02/2024
1	Toll-Like Receptor 2IBA 02/2024
1	CatecholaminesIBA 01/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	Poly I-CIBA 11/2023
1	Amyloidogenic ProteinsIBA 11/2023
1	Dihydrolipoyllysine-Residue Acetyltransferase (Dihydrolipoyl Transacetylase)IBA 01/2023
1	VaccinesIBA 01/2023
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	trametinibIBA 01/2023
1	Dopamine (Intropin)FDA LinkGeneric 12/2022
1	gambogic acidIBA 12/2022
1	GraphiteIBA 12/2022
1	Tigecycline (Tygacil)FDA Link 12/2022
1	EnzymesIBA 11/2022
1	Urea (Carbamide)FDA LinkGeneric 11/2022
1	ImmunosorbentsIBA 11/2022
1	InterleukinsIBA 10/2022
1	Heterogeneous-Nuclear Ribonucleoprotein Group C (HNRNP C Protein)IBA 10/2022

Therapy/Procedure

20	Therapeutics 11/2023 - 01/2013
10	Drug Therapy (Chemotherapy) 11/2023 - 01/2012
5	Photothermal Therapy 04/2024 - 09/2013
4	Quantum Dots (Quantum Dot) 03/2024 - 12/2022
4	Aftercare (After-Treatment) 01/2022 - 08/2013
3	Immunotherapy 01/2024 - 05/2020
2	Phototherapy (Light Therapy) 05/2022 - 01/2020
2	Length of Stay 06/2021 - 10/2019
2	Lasers (Laser) 03/2020 - 09/2013
1	Renal Dialysis (Hemodialysis) 10/2023
1	Adjuvant Radiotherapy 01/2023
1	Lymph Node Excision (Lymph Node Dissection) 01/2023
1	Hysterectomy 01/2023
1	Radiotherapy 01/2023